New monitor could prevent dangerous side effect of diabetes drug
NCT ID NCT07211802
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether wearing a continuous ketone monitor alongside a glucose monitor can reduce the risk of diabetic ketoacidosis (a serious side effect) when taking the drug sotagliflozin. About 52 adults with type 1 diabetes will take low and high doses of sotagliflozin while using the monitor. The goal is to see if the monitor helps keep ketone levels safe, potentially allowing more people to benefit from this drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sotagliflozin (low and high dose) and a dual continuous glucose/ketone monitor
- What this could lead to
- If successful, this could make SGLT inhibitors safer for people with type 1 diabetes, reducing the risk of diabetic ketoacidosis and improving blood sugar management.
- What could go wrong
- This is a small phase 3 trial with only 52 participants, so results may not apply to everyone. The ketone monitor's accuracy and the drug's side effects still pose risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
UCSD - Altman Clinical & Translational Research Institute
La Jolla, California, 92037, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Open-Source insulin systems match commercial ones without meal announcements?
- A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?
- AI takes the wheel: could a smart algorithm optimize insulin pumps from home?
- Could a metabolic modulator help people with type 1 diabetes use insulin better?
- Immune cell study may unlock kidney protection in type 1 diabetes
- Could an arthritis drug stop type 1 diabetes before it starts?